MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma

scientific article published on 01 July 2006

MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1078-0432.CCR-05-2814
P698PubMed publication ID16857800

P2093author name stringSurinder K Batra
Kohzoh Imai
Michiyo Higashi
Masamichi Goto
Suguru Yonezawa
Hiroaki Shibahara
Shugo Tamada
P2860cites workThe neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenQ52827123
P433issue14 Pt 1
P921main subjectextrahepatic bile duct carcinomaQ18556429
bile duct carcinomaQ11611688
P304page(s)4257-4264
P577publication date2006-07-01
P1433published inClinical Cancer ResearchQ332253
P1476titleMUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma
P478volume12

Reverse relations

cites work (P2860)
Q34796803A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor
Q34060189Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases
Q92029274Assessing the prognostic significance of MUC4β in mucoepidermoid carcinoma of the salivary glands: An immunohistochemical study
Q40694864Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori
Q33879485Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma
Q26784326Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis
Q88039920Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma
Q93184511Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas
Q57300567Current and future roles of mucins in cholangiocarcinoma-recent evidences for a possible interplay with bile acids
Q37187307Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours
Q38662233Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity
Q90260379Diversity of mucins in labial glands of infants
Q36001870Epigenetic regulation of mucin genes in human cancers
Q41465482Expression of MUC1 and MUC4 in gallbladder adenocarcinoma
Q37188897Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas
Q58122566Extracellular Vesicles in Hepatobiliary Malignancies
Q35035530Genetic variants in MUC4 gene are associated with lung cancer risk in a Chinese population
Q33963953High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma
Q37206290Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma
Q34477871MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer
Q36667483MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.
Q79847238MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells
Q37030117MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells.
Q24601584Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells
Q41379077Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer
Q36537065Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery.
Q34008828Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer.
Q33674729Muc4/MUC4 functions and regulation in cancer
Q36437150Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
Q24633765Mucins in cancer: function, prognosis and therapy
Q28070355Mucins in neoplasms of pancreas, ampulla of Vater and biliary system
Q64093534Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis
Q41922735Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?
Q35145588Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer
Q51802126Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
Q36053164Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis
Q36285659Prognostic significance of membrane-associated mucins 1 and 4 in gastric adenocarcinoma.
Q36406805Prognostic significance of muc4 expression in gallbladder carcinoma
Q34121441Prognostic significance of mucin expression in urothelial bladder cancer
Q34023248Prognostic value of mucin 4 expression in colorectal adenocarcinomas
Q39898076Promoter CpG methylation in cancer cells contributes to the regulation of MUC4.
Q40220702Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha.
Q48553032Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Q34493341The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
Q36127379Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies

Search more.